Hello,

I am doing my research in drug development related to skin autoimmune disease.

As an initial step in the in vitro part, which is better to use an Interleukin expressing cell line or a skin cell line to study the inhibition of some Interleukin related to skin autoimmune disease?

Similar questions and discussions